Biotech · Private company · Tucson, AZ, US
Fibronox, L.L.C.
Track this companyFree. Adds Fibronox, L.L.C. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Advanced Pre-clinical development of Nox4 inhibitors for Pulmonary FibrosisFiscal year 2025 · $1.1MNIH RePORTER 5R44HL172475-02 · fetched Nov 12, 2026
- Repurposing of FDA-approved Nrf2 Activators as a Novel Inhaled Therapy for Pulmonary FibrosisFiscal year 2024 · $286.7KNIH RePORTER 1R41HL174346-01 · fetched Nov 12, 2026
- Advanced Pre-clinical development of Nox4 inhibitors for Pulmonary FibrosisFiscal year 2024 · $954.7KNIH RePORTER 1R44HL172475-01A1 · fetched Nov 12, 2026